ALL NEWS

Pfizer says COVID-19 pill cut hospital, death risk by 90%

Nov 5, 2021, 5:37 AM | Updated: Aug 2, 2022, 12:35 pm

Pfizer COVID-19 pill...

FILE - This Feb. 5, 2021, file photo shows the Pfizer logo displayed at the company's headquarters in New York. Pfizer says its experimental pill for COVID-19 cut rates of hospitalization and death by nearly 90% among patients with mild-to-moderate infections. The company announced Friday, Nov. 5, it will soon ask the U.S. Food and Drug Administration and international regulators to authorize its pill, which is taken twice a day for five days. (AP Photo/Mark Lennihan, File)

(AP Photo/Mark Lennihan, File)

WASHINGTON (AP) — Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joins the race to bring the first easy-to-use medication against the coronavirus to the U.S. market.

Currently all COVID-19 treatments used in the U.S. require an IV or injection. Competitor Merck’s COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and on Thursday the United Kingdom became the first country to OK it.

Pfizer said it will ask the FDA and international regulators to authorize its pill as soon as possible, after independent experts recommended halting the company’s study based on the strength of its results. Once Pfizer applies, the FDA could make a decision within weeks or months.

Researchers worldwide have been racing to find a pill against COVID-19 that can be taken at home to ease symptoms, speed recovery and reduce the crushing burden on hospitals and doctors.

Pfizer released preliminary results Friday of its study of 775 adults. Patients taking the company’s drug along with another antiviral had an 89% reduction in their combined rate of hospitalization or death after a month, compared to patients taking a dummy pill. Fewer than 1% of patients taking the drug needed to be hospitalized and no one died. In the comparison group, 7% were hospitalized and there were seven deaths.

“We were hoping that we had something extraordinary, but it’s rare that you see great drugs come through with almost 90% efficacy and 100% protection for death,” said Dr. Mikael Dolsten, Pfizer’s chief scientific officer, in an interview.

Study participants were unvaccinated, with mild-to-moderate COVID-19, and were considered high risk for hospitalization due to health problems like obesity, diabetes or heart disease. Treatment began within three to five days of initial symptoms, and lasted for five days.

Pfizer reported few details on side effects but said rates of problems were similar between the groups at about 20%.

An independent group of medical experts monitoring the trial recommended stopping it early, standard procedure when interim results show such a clear benefit. The data have not yet been published for outside review, the normal process for vetting new medical research.

Top U.S. health officials continue to stress that vaccination will remain the best way to protect against infection. But with tens of millions of adults still unvaccinated — and many more globally — effective, easy-to-use treatments will be critical to curbing future waves of infections.

The FDA has set a public meeting later this month to review Merck’s pill, known as molnupiravir. The company reported in September that its drug cut rates of hospitalization and death by 50%. Experts warn against comparing preliminary results because of differences in studies.

Although Merck’s pill is further along in the U.S. regulatory process, Pfizer’s drug could benefit from a safety profile that is more familiar to regulators with fewer red flags. While pregnant women were excluded from the Merck trial due to a potential risk of birth defects, Pfizer’s drug did not have any similar restrictions. The Merck drug works by interfering with the coronavirus’ genetic code, a novel approach to disrupting the virus.

Pfizer’s drug is part of a decades-old family of antiviral drugs known as protease inhibitors, which revolutionized the treatment of HIV and hepatitis C. The drugs block a key enzyme which viruses need to multiply in the human body.

The drug, which has not yet been named, was first identified during the SARS outbreak originating in Asia during 2003. Last year, company researchers decided to revive the medication and study it for COVID-19, given the similarities between the two coronaviruses.

The U.S. has approved one other antiviral drug for COVID-19, remdesivir, and authorized three antibody therapies that help the immune system fight the virus. But they have to be given by IV or injection at hospitals or clinics, and limited supplies were strained by the last surge of the delta variant.

Shares of Pfizer spiked more than 9% before the opening bell Friday.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

We want to hear from you.

Have a story idea or tip? Send it to the KSL NewsRadio team here.

All News

Outside of the Yale University Law School is pictured on September 27, 2018 in New Haven, Connectic...

Zenebou Sylla, CNN

Some New England universities, including Yale, break $90,000 barrier for total tuition cost in upcoming school year

(CNN) — Several New England universities and colleges, including Yale, have reached a pinnacle of at least $90,000 for undergraduate tuition and costs starting this fall. Yale University, Tufts University, Boston University (BU), and Wellesley College are among a few private institutions that will top this year’s costs for tuition, housing and other expenses, according to […]

7 hours ago

A West Jordan man was arrested Tuesday for investigation of negligent homicide after he allegedly t...

Pat Reavy, ksl.com

West Jordan man shot, killed best friend while trying to ‘be funny,’ police say

A West Jordan man was arrested Tuesday for investigation of negligent homicide after shooting his "best friend."

8 hours ago

FILE: Cedar High School in Cedar City is pictured on Wednesday April 7, 2021....

Tammy Kikuchi and Emma Keddington

Cedar High School grapples with mascot name, five years after it was changed

The Iron School District Board of Education is grappling with changing the Cedar High School mascot back from "Reds" to "Redmen." 

8 hours ago

Dairy cows across the country, specifically in Texas, Kansas and New Mexico are getting sick with a...

Alexandrea Bonilla

Cows across the country are getting sick with a “flu-like” illness

Utah is altering the requirements for livestock brought into the state after multiple cows across the country have gotten sick with a flu-like illness.  

9 hours ago

FILE: The bust of 30 pounds of fentanyl in American Fork on March 21 highlights the drug problem Ut...

Heather Peterson and Curt Gresseth

DEA warns fentanyl most deadly drug in U.S. and Utah history

The DEA said Utah is on pace to see double the amount of fentanyl this year than last.

11 hours ago

The bodies of two men, ages 35 and 26, were recovered from the water, Col. Roland L. Butler Jr., se...

LEA SKENE and BRIAN WITTE Associated Press

Investigation of Baltimore bridge collapse picks up speed as divers recover 2 bodies from water

BALTIMORE (AP) — Investigators began collecting evidence Wednesday from the cargo ship that plowed into Baltimore’s Francis Scott Key Bridge and caused its collapse, while in the waters below divers searched through twisted metal for six construction workers who plunged into the harbor and were feared dead.   The bodies of two men, ages 35 and 26, […]

12 hours ago

Sponsored Articles

Mother and cute toddler child in a little fancy wooden cottage, reading a book, drinking tea and en...

Visit Bear Lake

How to find the best winter lodging in Bear Lake, Utah

Winter lodging in Bear Lake can be more limited than in the summer, but with some careful planning you can easily book your next winter trip.

Happy family in winter clothing at the ski resort, winter time, watching at mountains in front of t...

Visit Bear Lake

Ski more for less: Affordable ski resorts near Bear Lake, Utah

Plan your perfect ski getaway in Bear Lake this winter, with pristine slopes, affordable tickets, and breathtaking scenery.

front of the Butch Cassidy museum with a man in a cowboy hat standing in the doorway...

Bear Lake Convention and Visitors Bureau

Looking Back: The History of Bear Lake

The history of Bear Lake is full of fascinating stories. At over 250,000 years old, the lake has seen generations of people visit its shores.

silhouette of a family looking over a lake with a bird in the top corner flying...

Bear Lake Convention and Visitors Bureau

8 Fun Activities To Do in Bear Lake Without Getting in the Water

Bear Lake offers plenty of activities for the whole family to enjoy without having to get in the water. Catch 8 of our favorite activities.

Wellsville Mountains in the spring with a pond in the foreground...

Wasatch Property Management

Advantages of Renting Over Owning a Home

Renting allows you to enjoy luxury amenities and low maintenance without the long-term commitment and responsibilities of owning a home.

Clouds over a red rock vista in Hurricane, Utah...

Wasatch Property Management

Why Southern Utah is a Retirement Paradise

Retirement in southern Utah offers plenty of cultural and recreational opportunities. Find out all that this region has to offer.

Pfizer says COVID-19 pill cut hospital, death risk by 90%